Darin P Mcareavey

CIK 1365384 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 15, 2014 · Latest: Jan. 15, 2014

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 9 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

9 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 21, 2012 CREX P 1,700 $0.67 $1,139 28,700 Direct +6.30% Acquired -99.1% (price as of 2026-08-20)
May 21, 2012 CREX P 200 $0.66 $132 27,000 Direct +0.75% Acquired -99.0% (price as of 2026-08-20)
May 21, 2012 CREX P 100 $0.67 $67 26,800 Direct +0.37% Acquired -99.1% (price as of 2026-08-20)
May 18, 2012 CREX P 5,000 $0.56 $2,800 26,700 Direct +23.04% Acquired -98.9% (price as of 2026-08-20)
Aug. 25, 2011 CREX P 1,000 $1.14 $1,140 21,700 Direct +4.83% Acquired -99.4% (price as of 2026-08-20)
May 18, 2011 CREX P 1,900 $1.31 $2,489 20,700 Direct +10.11% Acquired -99.5% (price as of 2026-08-20)
May 18, 2011 CREX P 500 $1.30 $650 18,800 Direct +2.73% Acquired -99.5% (price as of 2026-08-20)
May 18, 2011 CREX P 1,600 $1.28 $2,048 18,300 Direct +9.58% Acquired -99.5% (price as of 2026-08-20)
Nov. 5, 2010 CREX P 1,000 $1.39 $1,390 16,700 Direct +6.37% Acquired -99.5% (price as of 2026-08-20)
Nov. 4, 2010 CREX P 290 $1.41 $409 15,700 Direct +1.88% Acquired -99.6% (price as of 2026-08-20)
Nov. 4, 2010 CREX P 1,390 $1.43 $1,988 15,410 Direct +9.91% Acquired -99.6% (price as of 2026-08-20)
Nov. 4, 2010 CREX P 320 $1.45 $464 14,020 Direct +2.34% Acquired -99.6% (price as of 2026-08-20)
June 3, 2010 CREX P 700 $1.27 $889 13,700 Direct +5.38% Acquired -99.5% (price as of 2026-08-20)
June 3, 2010 CREX P 600 $1.26 $756 13,000 Direct +4.84% Acquired -99.5% (price as of 2026-08-20)
June 3, 2010 CREX P 2,400 $1.26 $3,024 12,400 Direct +24.00% Acquired -99.5% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Jan. 14, 2014 CREX Stock Option (right to buy) [F2] Common Stock (50,000) $0.79 Jan. 14, 2024 50,000 Acquired
Feb. 13, 2013 CREX Stock Option (right to buy) [F2] Common Stock (25,000) $1.80 Feb. 13, 2023 25,000 Acquired
Feb. 16, 2012 CREX Stock Option (right to buy) [F2] Common Stock (50,000) $1.07 Feb. 16, 2022 50,000 Acquired
June 9, 2011 CREX Stock Option (right to buy) [F2] Common Stock (16,450) $1.17 March 23, 2021 16,450 Acquired
March 23, 2011 CREX Stock Option (right to buy) [F2] Common Stock (33,550) $1.17 March 23, 2021 33,550 Acquired
March 17, 2010 CREX Stock Option (right to buy) [F3] Common Stock (50,000) $2.45 March 17, 2020 50,000 Acquired
March 9, 2009 CREX Stock Option (right to buy) [F1] Common Stock (100,000) $1.12 March 9, 2019 100,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2012 $215,000 $0 $0 $400 $249,332
2011 $215,000,192,500 $0 $0 $417,443 $252,646,300,712
2009

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.